Eshboev Farkhod, Mamadalieva Nilufar, Nazarov Pavel A, Hussain Hidayat, Katanaev Vladimir, Egamberdieva Dilfuza, Azimova Shakhnoz
S. Yu. Yunusov Institute of the Chemistry of Plant Substances, Academy of Sciences of Uzbekistan, Mirzo Ulugbek Str. 77, Tashkent 100170, Uzbekistan.
School of Chemical Engineering, New Uzbekistan University, Movarounnahr Street 1, Mirzo Ulugbek District, Tashkent 100000, Uzbekistan.
Antibiotics (Basel). 2024 Mar 18;13(3):271. doi: 10.3390/antibiotics13030271.
Infectious diseases are a significant challenge to global healthcare, especially in the face of increasing antibiotic resistance. This urgent issue requires the continuous exploration and development of new antimicrobial drugs. In this regard, the secondary metabolites derived from endophytic microorganisms stand out as promising sources for finding antimicrobials. Endophytic microorganisms, residing within the internal tissues of plants, have demonstrated the capacity to produce diverse bioactive compounds with substantial pharmacological potential. Therefore, numerous new antimicrobial compounds have been isolated from endophytes, particularly from endophytic fungi and actinomycetes. However, only a limited number of these compounds have been subjected to comprehensive studies regarding their mechanisms of action against bacterial cells. Furthermore, the investigation of their effects on antibiotic-resistant bacteria and the identification of biosynthetic gene clusters responsible for synthesizing these secondary metabolites have been conducted for only a subset of these promising compounds. Through a comprehensive analysis of current research findings, this review describes the mechanisms of action of antimicrobial drugs and secondary metabolites isolated from endophytes, antibacterial activities of the natural compounds derived from endophytes against antibiotic-resistant bacteria, and biosynthetic gene clusters of endophytic fungi responsible for the synthesis of bioactive secondary metabolites.
传染病对全球医疗保健构成重大挑战,尤其是面对日益增加的抗生素耐药性时。这个紧迫的问题需要不断探索和开发新的抗菌药物。在这方面,源自内生微生物的次生代谢产物作为寻找抗菌剂的有希望的来源而脱颖而出。内生微生物存在于植物内部组织中,已证明能够产生具有巨大药理潜力的多种生物活性化合物。因此,许多新的抗菌化合物已从内生菌中分离出来,特别是从内生真菌和放线菌中分离出来。然而,这些化合物中只有少数对其针对细菌细胞的作用机制进行了全面研究。此外,仅对这些有前景的化合物中的一部分进行了它们对耐抗生素细菌的影响的研究以及负责合成这些次生代谢产物的生物合成基因簇的鉴定。通过对当前研究结果的全面分析,本综述描述了从内生菌中分离出的抗菌药物和次生代谢产物的作用机制、内生菌衍生的天然化合物对耐抗生素细菌的抗菌活性以及负责生物活性次生代谢产物合成的内生真菌的生物合成基因簇。